REWARD will open up new horizons in complementing the international intellectual property rights (IPR) system. The project's ambitious output is an ethically and legally sound performance-based reward tool for pharmaceutical innovation, which complements the existing patent regime, yet mitigates its considerable disadvantages for the global poor.
Many international research groups are working on IPR reform plans based on performance-based rewards (PBR) for pharmaceutical innovation. However, their efforts are disparate and lacking a guiding vision. REWARD will use world-class ethics research as the steering force to determine which PBR tools for pharmaceutical innovation are the most promising. In an interdisciplinary collaboration of ethicists, lawyers, economists and statisticians, with experts in medicine, science and technology policy and gender studies the selected tool will be tested in a developed and a developing country.
To find out more about this project, contact Professor Doris Schroeder.
ERC European Research Council, 1,922,338 Euros
2014 - 2019